SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 631.40 |
| Enterprise Value ($M) | 790.38 |
| Book Value ($M) | 84.37 |
| Book Value / Share | 2.77 |
| Price / Book | 7.48 |
| NCAV ($M) | 39.63 |
| NCAV / Share | 1.30 |
| Price / NCAV | 15.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.37 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -1.38 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.23 |
| Current Ratio | 10.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 448.68 |
| Assets | 493.42 |
| Liabilities | 409.05 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Tang Capital Management Llc | 4.40 | ||
| 13D/A | EcoR1 Capital, LLC | 25.80 | 3.65 | |
| 13G | Fmr Llc | 10.51 | 1,515.07 | |
| 13G | Frazier Life Sciences Public Fund, L.P. | 7.00 | ||
| 13G/A | Tang Capital Partners Lp | 7.30 | -25.80 | |
| 13G/A | Point72 Asset Management, L.P. | 3.00 | -62.88 | |
| 13G/A | Vanguard Group Inc | 5.19 | -22.33 | |
| 13G/A | BlackRock Inc. | 6.80 | -3.04 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 58,925 | 294,584 | 20.00 | |
| 63,265 | 299,090 | 21.15 | |
| 80,845 | 405,285 | 19.95 | |
| 85,881 | 402,249 | 21.35 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AMLX – Amylyx Pharmaceuticals, Inc. | AMPH – Amphastar Pharmaceuticals, Inc. |
| AMRX – Amneal Pharmaceuticals, Inc. | ANNX – Annexon, Inc. |
| APLS – Apellis Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io